The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.
de Bruijne EL, Gils A, Guimarães AH, Dippel DW, Deckers JW, van den Meiracker AH, Poldermans D, Rijken DC, Declerck PJ, de Maat MP, Leebeek FW.
de Bruijne EL, et al. Among authors: leebeek fw.
J Thromb Haemost. 2009 Jun;7(6):919-27. doi: 10.1111/j.1538-7836.2009.03350.x. Epub 2009 Mar 23.
J Thromb Haemost. 2009.
PMID: 19323787
Free article.